74
Participants
Start Date
March 31, 2016
Primary Completion Date
September 26, 2024
Study Completion Date
September 26, 2024
somapacitan
Administered subcutaneously (s.c., under the skin) once-weekly.
Norditropin® FlexPro® pen
Administered subcutaneously (s.c., under the skin) once daily.
NNC0195-0092
Administered subcutaneously (s.c., under the skin) once-weekly.
Brussels
University Children's Hospital, Ljubljana
Ljubljana
Kepler Universitätsklinikum GmbH - Med Campus IV (vorm.LFKK), Linz
Graz
Landeskrankenhaus Villach, Villach
Novo Nordisk Clinical Trial Call Center, Mineola
NYU Langone Hospital-LI, Mineola
Nemours/AI duPont Hosp-Chld, Wilmington
Hôpital des Enfants, Toulouse
Rambam Medical Center Children A Dept., Haifa
CHU Pellegrin, Bordeaux
Bordeaux
Istanbul
Marmara University Medical Faculty, Istanbul
HOPITAL SUD de RENNES, Rennes
Clinique Médicale Pédiatrique, Nantes
Department of Pediatrics , Meir Medical Center, Kfar Saba
Kfar Saba
CCHMC_Cinc, Cincinnati
Novo Nordisk Clinical Trial Call Center, Cincinnati
Centre Hospitalier Régional Universitaire d' Angers, Angers
Endrocrinology & DM Schneider MC, Petah Tikva
Sheba Medical Center Pediatric Endocrinology, Tel Litwinsky
Novo Nordisk Clinical Trial Call Center, Minneapolis
Frankfurt
Endokrinologikum Frankfurt, Frankfurt am Main
Hôpital Necker, Paris
Ivano-Frankivsk Regional Clinical Children Hospital, Ivano-Frankivsk
Soroka Medical Center - Pediatric Endocrinology, Beersheba
Deutsches Zentrum für Kinder- und Jugendgesundheit (DZKJ), Ulm
Novo Nordisk Clinical Trial Call Center, San Diego
All India Institute of Medical Sciences, New Dehli
New Dehli
Jehangir Clinical Development Centre, Pune
Amrita Institute Of Medical Sciences & Research Centre, Kochi
Goryeb Children's Hospital, Morristown
Novo Nordisk Clinical Trial Call Center, Morristown
Rutgers-Rwjms, New Brunswick
CPQuali Pesquisa Clínica Ltda, São Paulo
São Paulo
Kurume University Hospital, Pediatrics, Fukuoka
St. Marianna University School of Medicine Hospital_Pediatrics, Kanagawa
Univ.HP, Kyoto Pref Univ of Medicine, Dept. of Pediatrics, Kyoto
Osaka City General Hospital, Pediatric Endocrinology and Me, Osaka
Osaka Women's and Children's Hospital, Osaka
Institute of Science Tokyo Hospital, Tokyo
Tokyo Medical and Dental University Hospital, Tokyo
National Center for Child Health and Dev, Endo and Metabo, Tokyo
Tokyo
Astrid Lindgrens Barnsjukhus, Stockholm
Stockholm
Kiev
Institute of Endocrinology and Metabolism of AMSU, Kyiv
Lead Sponsor
Novo Nordisk A/S
INDUSTRY